Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Traldi

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Medicina (Kaunas, Lithuania)|March 29, 2023
Mass Spectrometry Contribution to Pediatric Cancers ResearchMarco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Endocrinology|April 11, 2013
Protein glycation in diabetes as determined by mass spectrometryAnnunziata Lapolla, Laura Molin, Pietro Traldi
ISRN Endocrinology|June 12, 2012
Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physiciansAnnunziata Lapolla, Simona Porcu, Pietro Traldi
Cells|February 12, 2026
Does the B7-H3 Immune Checkpoint Have High Potential as a Therapeutic Target?Marco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Molecular Sciences|September 14, 2024
Proteomic Investigation of Immune Checkpoints and Some of Their InhibitorsMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Medicina (Kaunas, Lithuania)|October 28, 2023
Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease BiomarkersMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Journal of Personalized Medicine|June 25, 2026
Immune Cell Therapy Promises More Effective Cure for MedulloblastomaMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Clinical Chemistry and Laboratory Medicine|March 18, 2011
Some views on proteomics in diabetesAnnunziata Lapolla, Simona Porcu, Pietro Traldi
Cancers|March 28, 2025
Programmed Cell Death Ligand as a Biomarker for Response to Immunotherapy: Contribution of Mass Spectrometry-Based AnalysisMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Clinical Biochemistry|January 12, 2005
Importance of measuring products of non-enzymatic glycation of proteinsAnnunziata Lapolla, Pietro Traldi, Domenico Fedele
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Medicina (Kaunas, Lithuania)|March 29, 2023
Mass Spectrometry Contribution to Pediatric Cancers ResearchMarco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Endocrinology|April 11, 2013
Protein glycation in diabetes as determined by mass spectrometryAnnunziata Lapolla, Laura Molin, Pietro Traldi
ISRN Endocrinology|June 12, 2012
Mass spectrometry for diabetic nephropathy monitoring: new effective tools for physiciansAnnunziata Lapolla, Simona Porcu, Pietro Traldi
Cells|February 12, 2026
Does the B7-H3 Immune Checkpoint Have High Potential as a Therapeutic Target?Marco Agostini, Pietro Traldi, Mahmoud Hamdan
International Journal of Molecular Sciences|September 14, 2024
Proteomic Investigation of Immune Checkpoints and Some of Their InhibitorsMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Medicina (Kaunas, Lithuania)|October 28, 2023
Mass Spectrometry-Based Proteomics: Analyses Related to Drug-Resistance and Disease BiomarkersMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Journal of Personalized Medicine|June 25, 2026
Immune Cell Therapy Promises More Effective Cure for MedulloblastomaMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Clinical Chemistry and Laboratory Medicine|March 18, 2011
Some views on proteomics in diabetesAnnunziata Lapolla, Simona Porcu, Pietro Traldi
Cancers|March 28, 2025
Programmed Cell Death Ligand as a Biomarker for Response to Immunotherapy: Contribution of Mass Spectrometry-Based AnalysisMarco Agostini, Pietro Traldi, Mahmoud Hamdan
Clinical Biochemistry|January 12, 2005
Importance of measuring products of non-enzymatic glycation of proteinsAnnunziata Lapolla, Pietro Traldi, Domenico Fedele
Pageof 17